Y-Intercept (HK)’s Abeona Therapeutics ABEO Stock Holding History

Y-Intercept (HK)’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$884K	Buy	168,334 +95,961	+133%	+$596K	0.02%	1066
2026 Q2	$447K	Buy	+72,373	New	+$397K	0.01%	1343
2025 Q3	–	Sell	-102,336	Closed	-$581K	–	1513
2025 Q2	$581K	Buy	+102,336	New	+$583K	0.01%	1152
2024 Q2	–	Sell	-14,023	Closed	-$102K	–	1326
2024 Q1	$102K	Buy	14,023 +3,609	+35%	+$22.9K	0.01%	1277
2023 Q4	$52.2K	Buy	+10,414	New	+$45.8K	﹤0.01%	1159
2021 Q3	–	Sell	-609	Closed	-$24K	–	617
2021 Q2	$24K	Buy	+609	New	+$24.8K	0.01%	578

Other funds holding ABEO

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Y-Intercept (HK)'s ABEO Position: Q3 2026 in Review

Y-Intercept (HK) increased its Abeona Therapeutics (ABEO) stake by 133% in Q3 2026, buying an estimated $596K and bringing the position to 168,334 shares worth $884K. The position accounts for 0.02% of the portfolio, ranked #1066.

Y-Intercept (HK) first reported a position in ABEO in Q2 2021 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

Y-Intercept (HK) held 168,334 shares of Abeona Therapeutics worth $884K as of Q3 2026.
Y-Intercept (HK) bought 95,961 Abeona Therapeutics shares in Q3 2026, an estimated $596K.
Abeona Therapeutics made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1066 holding.
Y-Intercept (HK) first reported a position in Abeona Therapeutics in Q2 2021 and has held it in 6 quarters since.
10 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.